INTRODUCTION
The prolactin-stimulating activity of the avian hypothalamus has been well documented. Since Kragt & Meites (1965) and Nicoli (1965) first detected prolactin-releasing activity in the hypothalamus of the pigeon and tricoloured blackbird, similar findings have been reported for the turkey, blackbird, duck, quail and domestic fowl (Chen, Bixler, Weber & Meites, 1968; Nicoli, Fiorindo, McKenee & Parsons, 1970; Tixier-Vidal & Gourdji, 1972; Hall, Chadwick, Bolton & Scanes, 1975; Knight & Chadwick, 1975; Hall & Chadwick, 1982) . The avian hypothalamus may contain prolactin-inhibiting activity also (Nicoli et al. 1970; Tixier-Vidal & Gourdji, 1972; Knight & Chadwick, 1975; Bolton, Chadwick, Hall & Scanes, 1976 ) and a growth hormone-releasing principle (Müller, Sawano & Schally, 1968; Hall & Chadwick, 1975) .
Some mammalian releasing and release-inhibiting hormones have been synthesized and affect the release of avian pituitary hormones. Thyrotrophin releasing hormone (TRH) stimulates release of avian thyroid-stimulating hormone, prolactin and growth hormone in vitro (Scanes, 1974; Hall et al. 1975 ) and in vivo (Harvey, Scanes, Chadwick & Bolton, 1978) . Synthetic mammalian somatostatin inhibits release of growth hormone from fowl pituitary glands incubated in vitro (Hall & Chadwick, 1975 .
In mammals, release of the hypothalamic hormones may be regulated by brain neurotransmitters (Clemens, 1976; MacLeod, 1976) . The effects of neurotransmitters, in particular the monoamines, on release of pituitary hormones in birds has received some study. Tixier-Vidal & Gourdji (1972) suggested that reserpine, a monoamine storage depletor, stimulates release of prolactin, indicating the presence of a prolactin-inhibiting factor as in mammals. Hall & Chadwick (1982) found that L-dihydroxyphenylalanine inhibited release of prolactin from fowl pituitary-hypothalamus co-incubations. Nistico, Germana, Ciriaco, Bronzetti, Rotiroti & Scapagnini (1979) and Nistico, Germana, Ciriaco & Bronzetti (1980) (Hall et al. 1975 ). The prolactin (Nicoli & Nichols, 1971; and growth hormone (Nicoli & Licht, 1971; Harvey & Scanes, 1977) 
DISCUSSION
From mammalian studies it is believed that the mechanism triggering the release of the hypothalamic hormones involves the brain neurotransmitters. Changes in neurotransmitter output and in particular alterations in secretion of the monoamines, dopamine, noradrenaline and serotonin, have been associated with many hormonal changes in mammals (Chen, Mueller & Meites, 1974 ; Advis, Simpkins, Chen & Meites, 1978) . There is a large body of evidence indicating that dopamine is involved in the control of prolactin secretion in mammals. Drugs which decrease secretion of dopamine have been found to increase secretion of prolactin, and conversely, drugs which increase secretion of dopamine reduce the secretion of prolactin (MacLeod, 1976) . In vitro, dopamine inhibited the release of prolactin directly from the mammalian pituitary gland, an effect reversed by the receptor blocker, pimozide (Clemens, 1976) . Dopamine has been reported to possess both growth hormone releasing and inhibiting activities in mammals, although these effects are mediated through the hypothalamus (Martin, 1976) . Serotonin is known to stimulate prolactin release in mammals, through a hypothalamic mechanism (Clemens, 1976) and similarly, serotonin appears to stimulate release of mammalian growth hormone (Martin, 1976) . The serotonin receptor blocker, methysergide, inhibited these responses.
Reserpine, which is known to induce prolactin release in mammals, presumably by depleting the prolactin-inhibiting monoamine, dopamine (MacLeod, 1976 ), also appears to stimulate avian prolactin secretion (Tixier-Vidal & Gourdji, 1972) . Nistico et al. (1979 Nistico et al. ( , 1980 (Clemens, 1976) , amphibians (G. Urueña & T. R. Hall, unpublished observations) and teleosts (Olivereau, 1978; Olcese, Hall, Figueroa & de Vlaming, 1979) . Control of growth hormone secretion in the pigeon appears to differ from that in mammals, since in the pigeon dopamine stimulates, whereas serotonin inhibits, release of pituitary growth hormone through a hypothalamic mechanism. Whether the neurotransmitters act through a growth hormone-releasing (Hall & Chadwick, 1975) or a growth hormone-inhibiting (Hall & Chadwick, 1975 factor is not known at present.
